Concepedia

Douglas S. Greene

DS

37

Publications

1.2K

Citations

20

H-Index

1976

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Germany)

University of Rhode Island

University of Connecticut

Bristol-Myers Squibb (Sweden)

Douglas S. Greene is an author at Bristol-Myers Squibb (United States) specializing in pharmacology, medicine, and pharmacokinetics.

ORCID

Top concepts

Publications per year

1976–2020

37

Publications

37

Effect of altered gastric emptying and gastrointestinal motility on metformin absorption

Punit H. Marathe, Yandong Wen, Jean Norton et al. · British Journal of Clinical Pharmacology · 2000 · 123 citations · Full text

, , +17

Coadministration of Nefazodone and Benzodiazepines

Rashmi H. Barbhaiya, Umesh Shukla, Patricia D. Kroboth et al. · Journal of Clinical Psychopharmacology · 1995 · 97 citations

In vitro–in vivo correlation (IVIVC) models for metformin after administration of modified‐release (MR) oral dosage forms to healthy human volunteers

Guhan Balan, Peter Timmins, Douglas S. Greene et al. · Journal of Pharmaceutical Sciences · 2001 · 87 citations

, , +7

Effects of the ACAT inhibitor CL 277,082 on cholesterol metabolism in humans

William S. Harris, Carlos A. Dujovne, Klaus von Bergmann et al. · Clinical Pharmacology & Therapeutics · 1990 · 80 citations

Single-dose pharmacokinetics of piperacillin and tazobactam in patients with renal disease

Curtis A. Johnson, Charles E. Halstenson, J S Kelloway et al. · Clinical Pharmacology & Therapeutics · 1992 · 73 citations

Rows per page

1–5 of 37